- Weis' Deal Likely Won't Change Big Money Contracts
- Time Lapse World Series Is A Great Play
- Boise State Stock Plan: An Early Success
- Dollar Signs Seen In Young "Buck" Jennings
- Iverson Wasn't A Popular "Answer"
- My Top 10 Marketing Ideas For Winless Nets
- Airlines Add 'Super Bowl' Tax
- Chicken Wing Finder Makes Debut
- Michelle Wie Wins, Now What?
- TV Series Inks Unique Deal For Fight
RSS FEED
MOST SHARED
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- Why Amazon Rules Retail
- Gold Will Collapse Like Oil Did in 2008: Charts
- Wave of Debt Payments Facing US Government
- China Eastern to Complete Shanghai Air Buy by End '09
- Weak Dollar Is Golden for Mining Companies
- JAL Slides to Record Low on Bankruptcy Jitters
- Paul: Audit the Fed
- Nielsen Ratings Coming to Video Games
- How Many US Consumers Will Shop this Weekend?
- 5 Stocks That Benefit from Health Care Legislation: Analysts
- Can Murdoch Help Bing Challenge Google and Shift the Content Equation?
- HP's Mark Hurd
- HP Comes in As Expected; Is It Time to Buy?
- 9 Stocks That Play Rising Water Costs: Strategists
- Weis' Deal Likely Won't Change Big Money Contracts
- Gold Prices Can Double in 3 Years: Portfolio Manager
- Nov. 23: Unusual Volume Leaders
- Help Wanted—Please Run $4 Billion University
- Revised GDP Reading Puts Growth at 2.8%; Inflation Tame
- Strong Banks, Weak Credit: Treasury Rethinks TARP
- Weak Dollar Is Golden for Mining Companies
- How Many US Consumers Will Shop this Weekend?
- Tuesday's Heavy Dose of Data to Dictate 'Risk' Behavior
- GE Capital Losses May See Dramatic Fall: JP Morgan
- Galleon's Rajaratnam Denies Inside Trading Charges
- Hormel Profit Jumps Despite Declining Sales
- Heinz Profit Falls, Raises Full-Year View
Sports Biz
![]() |
Although the information each time has been sketchy, the names Kellen Winslow, Tom Brady and Peyton Manning have become associated with it in recent weeks. MRSA is called a “Superbug” because it is resistant to a bevy of antibiotics and therefore can be fatal. That’s created this humungous industry of MRSA combatants.
Cepheid: It’s a publicly traded molecular diagnostics company [CPHD
Loading...
()
] that makes a test called the GeneXpert test that detects MRSA. The test supposedly identifies someone who has MRSA within an hour. A usual culture takes as much as three days.
Byotrol: A British company that makes an anti-microbial that combats MRSA and they say works to kill the microorganisms days after it has been applied. Another selling point is that it requires no special protection when applying it.
GagaGen: A biotechnology company that is working on MRSA-resistant products. Received $1.8 million in funding earlier this month for the project.
Himalayan Oregano: A research team is currently investigating the properties of Himalayan oregano oils as an antibacterial agent against MRSA.
Honeymark International: Sells an antiseptic lotion made with manuka honey, one of the only natural substances that has been known to fight off MRSA.
Pure Green: Makes disinfectant and deodorizer that kills MRSA.
Rib-X Pharmaceuticals: Currently developing an antibiotic named Delafloxacin, which kills off a broad spectrum of bacteria including MRSA.
Sana Systems: This company headed by a Los Angeles martial arts school owner makes a new line of products called Athletic Body Care. Says its skin sanitizer, power wash, defense lotion and muscle soak kills 99 percent of germs, including MRSA.
TaiGen Biotechnology: Currently testing a MRSA killing drug called Nemonoxacin.
Tec Laboratories: Makes a product called Staphseptic that it markets to athletic trainers.
More from SportsBiz
Questions? Comments?










